Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial

American Journal of Cardiology

Volumn 90, Issue 2, 2002, Pages 89-94

  Rosenson, Robert S ^a   Otvos, James D ^b   Freedman, David S ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR SIZE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; PRAVASTATIN; TREATMENT OUTCOME;

EID: 0037099259     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02427-X     Document Type: Article

References (26)

1. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
2. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial
3. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy
4. Hepatic lipase influences high density lipoprotein subclass distribution in normotriglyceridemic men: Genetic and pharmacological evidence
5. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease
6. Lipid lowering, regression, and coronary events: A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting
7. Lipoprotein subclasses in the monitored atherosclerosis regression study (MARS): Treatment effects and relation to coronary angiographic progression
8. Evidence for a new pathophysiological mechanism for coronary artery disease regression: Hepatic lipase-mediated changes in LDL density
9. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men
10. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system
11. 2 and small, dense low-density lipoprotein
12. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
13. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease
14. Low-density lipoprotein size, pravastatin treatment, and coronary events
15. Is the size of low-density lipoprotein particles related to the risk of coronary heart disease?
16. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease
17. Alterations in the concentration of an apolipoprotein-E-containing subfraction of plasma high-density lipoprotein in coronary heart disease
18. High-density lipoproteins and coronary atherosclerosis: A strong inverse relation with the largest particles is confined to normotriglyceridemic patients
19. Altered particle size distribution of apolipoprotein A-1-containing lipoproteins in subjects with coronary artery disease
20. Distribution of apoA-1-containing HDL subpopulations in patients with coronary disease
21. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
22. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women
23. How high-density lipoprotein protects against the effects of lipid peroxidation
24. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
25. Atherogenesis: A postprandial phenomenon